New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries, including osteoporosis and gout.

Investigators are working to determine the identity and cause of death of a person whose skeletal remains were found along a remote stretch of desert road near Barstow this week. The bones, which ...

In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

Human trafficking continues to be a global threat driven by organized crime. More and more victims are being trafficked every year, across greater distances, with greater violence, for longer periods ...

Rajkot: A week after he went missing, the body of a 47-year-old real estate businessman from Morbi was found on Thursday, buried in a closed factory c.

Omada Health (Nasdaq: OMDA), the virtual-first provider of between-visit care, today announced GLP-1 Flex Care, a new offering that will support employers looking to increase access to GLP-1 ...

Neuroscience examines the structure and function of the human brain and nervous system. Neuroscientists use cellular and molecular biology, anatomy and physiology, human behavior and cognition, and ...

This article examines how exercise-induced exerkines prevent disease, as well as promote metabolic, cardiovascular, immune, ...

Pain Management Devices Market OutlookThe global pain management devices market is projected to expand at a compound annual growth rate (CAGR) of approximately 9% over the forecast period, driven by ...

This case study by Teurai Anna Nyamangara and Marcelle Mardon examines the intersection of gender, extreme urban heat and ...

Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...

HERNEXEOS product image Product image This press release is not intended for UK media HERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as demonstrated in the ...